Kathleen Pelletier

Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened

Michael J. Munchhof, Qifang Li, Andrei Shavnya et al. · ACS Medicinal Chemistry Letters · 2011 · 160 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Mechanistic Investigation of the Preclinical Pharmacokinetics and Interspecies Scaling of PF-05231023, a Fibroblast Growth Factor 21–Antibody Protein Conjugate

Craig Giragossian, Chandra Vage, Jun Li et al. · Drug Metabolism and Disposition · 2015 · 20 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Feasibility of Singlet Analysis for Ligand Binding Assays: a Retrospective Examination of Data Generated Using the Gyrolab Platform

Tracey Clark, Phillip D. Yates, Allison G. Chunyk et al. · The AAPS Journal · 2016 · 19 citations

Medicine, Molecular Biology, Pharmacology +10

Safety, Tolerability, and Pharmacokinetics of PF‐06823859, an Anti–Interferon β Monoclonal Antibody: A Randomized, Phase I, Single‐ and Multiple‐Ascending‐Dose Study

Srividya Neelakantan, Barry S. Oemar, Kristen Johnson et al. · Clinical Pharmacology in Drug Development · 2020 · 19 citations

Pharmacy, Pharmacokinetics, Pharmacology +13